Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for pharmaceutical and biotechnology companies. The company operates through two segments, Ypsomed Delivery Systems and Ypsomed Diabetes Care. The Ypsomed Delivery Systems segment provides various injection systems, such as pen injectors, auto injectors, and wearable injectors, as well as other smart devices. This segment offers its products under the YDS brand. The Ypsomed Diabetes Care segment sells and trades in insulin pumps, infusion sets, pen needles, blood glucose monitoring systems, accessories, and other day-to-day items for diabetics. This segment offers its products under the mylife brand name. The company offers precision turned parts; and contract manufacturing and other services. It markets its products through pharmaceutical partners, as well as through its own distribution network and independent distributors. It operates in Switzerland, Europe, North America, and internationally. Ypsomed Holding AG was founded in 1984 and is headquartered in Burgdorf, Switzerland.
| 496.25 | |
| 496.25 | |
| - | |
| 496.25 | |
| 496.25 | |
| 148.7204-496.25 | |
| 6 795 M | |
| 72.9779 | |
| 13 650 K | |
| 548 M | |
| 0.0045 | |
| 0.973 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Key Insights Significant insider control over Ypsomed Holding implies vested interests in company growth 72% of the company is held by a single shareholder (H. C. Michel) Institutions own 11% of Ypso...
Ypsomed Holding's (VTX:YPSN) stock is up by a considerable 24% over the past three months. We wonder if and what role the company's financials play in that price change as a company's long-term fundam...
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
